Freeze-drying a biodegradable polymer, poly(L-lactic acid) (PLLA), from 1,4-dioxane solutions provided very porous spherical particles of ca. 3?mm in radius with specific surface area of 8–13?m2 g?1. The surface of the particle was found to be less porous compared with its interior. To apply the freeze-dried PLLA (FDPLLA) to drug delivery system, its morphology and drug releasing kinetics were investigated, bovine serum albumin (BSA) being used as a model drug compound. Immersion of FDPLLA into a BSA aqueous solution gave BSA-loaded FDPLLA, where mass fraction of the adsorbed BSA reached up to 79%. Time-dependent release profile of BSA in water suggested a two-step mechanism: (1) very rapid release of BSA deposited on and near the particle surface, which results in an initial burst, and (2) leaching of BSA from the interior of the particle by the diffusion process. It was suggested that the latter process is largely governed by the surface porosity. The porosity of both the interior and surface was found to decrease remarkably as the concentration of the original PLLA/1,4-dioxane solution increases, C0. Thus, C0 is a key parameter that controls the loading and releasing of BSA. 1. Introduction In recent decades, controlled drug release from capsules made from biodegradable and biocompatible polymers has been extensively studied. Polymer microspheres with dispersed medication are often used for this purpose [1]. In general, the drug release from microspheres are considered to occur both by degradation of the polymer matrix and by simple diffusion of the drug molecules. It has been revealed that various factors affect the feature of drug release, such as the size and structure of the microsphere, porosity, chemistry, degradability, and molar mass of the polymer material, and pH value of the medium [1]. Furthermore, pH-sensitive release technique has been developed [2–4]. Microspheres for the drug release have been prepared by polymerization method or by solvent removing method [1]. Vinyl polymer microcapsules can be prepared by emulsion, suspension, or dispersion polymerization [1, 5]. Furthermore, controlled/living radical polymerization, which has been developed recently, can provide microspheres with well-controlled morphology [6]. On the other hand, for biodegradable polymers such as poly(L-lactic acid) (PLLA), poly(glycolic acid) (PGA), and various naturally occurring polymers, microspheres are usually prepared by solvent evaporation or spray-drying method [7–17]. It needs to be noted that porous biodegradable polymer particles can also be prepared
References
[1]
S. Freiberg and X. X. Zhu, “Polymer microspheres for controlled drug release,” International Journal of Pharmaceutics, vol. 282, no. 1-2, pp. 1–18, 2004.
[2]
D. M. Lynn, M. M. Amiji, and R. Langer, “pH-responsive polymer microspheres: rapid release of encapsulated material within the range of intracellular pH,” Angewandte Chemie-International Edition, vol. 40, no. 9, pp. 1707–1710, 2001.
[3]
K. C. Gupta and M. N. V. Ravi Kumar, “pH dependent hydrolysis and drug release behavior of chitosan/poly(ethylene glycol) polymer network microspheres,” Journal of Materials Science: Materials in Medicine, vol. 12, no. 9, pp. 753–759, 2001.
[4]
E. J. Kim, S. H. Cho, and S. H. Yuk, “Polymeric microspheres composed of pH/temperature-sensitive polymer complex,” Biomaterials, vol. 22, no. 18, pp. 2495–2499, 2001.
[5]
F. Tiarks, K. Landfester, and M. Antonietti, “Preparation of polymeric nanocapsules by miniemulsion polymerization,” Langmuir, vol. 17, no. 3, pp. 908–918, 2001.
[6]
P. B. Zetterlund, Y. Kagawa, and M. Okubo, “Controlled/living radical polymerization in dispersed systems,” Chemical Reviews, vol. 108, no. 9, pp. 3747–3794, 2008.
[7]
R. Jalil and J. R. Nixon, “Microencapsulation using poly(L-lactic acid) I: microcapsule properties affected by the preparative technique,” Journal of Microencapsulation, vol. 6, no. 4, pp. 473–484, 1989.
[8]
R. Jalil and J. R. Nixon, “Microencapsulation using poly(L-lactic acid) IV: release properties of microcapsules containing phenobarbitone,” Journal of Microencapsulation, vol. 7, no. 1, pp. 53–66, 1990.
[9]
G. Crotts and T. G. Park, “Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues,” Journal of Microencapsulation, vol. 15, no. 6, pp. 699–713, 1998.
[10]
X. L. Bai, Y. Y. Yang, T. S. Chung, et al., “Effect of polymer compositions on the fabrication of poly(ortho-ester) microspheres for controlled release of protein,” Journal of Applied Polymer Science, vol. 80, no. 10, pp. 1630–1642, 2001.
[11]
R. T. Liggins and H. M. Burt, “Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers,” International Journal of Pharmaceutics, vol. 222, no. 1, pp. 19–33, 2001.
[12]
R. T. Liggins and H. M. Burt, “Paclitaxel loaded poly(L-lactic acid) (PLLA) microspheres: II. The effect of processing parameters on microsphere morphology and drug release kinetics,” International Journal of Pharmaceutics, vol. 281, no. 1-2, pp. 103–106, 2004.
[13]
K. Makino, T. Mogi, N. Ohtake et al., “Pulsatile drug release from poly (lactide-co-glycolide) microspheres: how does the composition of the polymer matrices affect the time interval between the initial burst and the pulsatile release of drugs?” Colloids and Surfaces B, vol. 19, no. 2, pp. 173–179, 2000.
[14]
S. Zhou, X. Deng, M. Yuan, and X. Li, “Investigation on preparation and protein release of biodegradable polymer microspheres as drug-delivery system,” Journal of Applied Polymer Science, vol. 84, no. 4, pp. 778–784, 2002.
[15]
U. Paiphansiri, P. Tangboriboonrat, and K. Landfester, “Polymeric nanocapsules containing an antiseptic agent obtained by controlled nanoprecipitation onto water-in-oil miniemulsion droplets,” Macromolecular Bioscience, vol. 6, no. 1, pp. 33–40, 2006.
[16]
F. Pavanetto, I. Genta, P. Giunchedi, and B. Conti, “Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation,” Journal of Microencapsulation, vol. 10, no. 4, pp. 487–497, 1993.
[17]
C. Witschi and E. Doelker, “Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing,” Journal of Controlled Release, vol. 51, no. 2-3, pp. 327–341, 1998.
[18]
T. Sasaki, N. Yamauchi, S. Irie, and K. Sakurai, “Differential scanning calorimetry study on thermal behaviors of freeze-dried poly(L-lactide) from dilute solutions,” Journal of Polymer Science, Part B, vol. 43, no. 2, pp. 115–124, 2005.
[19]
T. Sasaki, R. Asakawa, and K. Sakurai, “Formation of porous spherulites of poly(L-lactide) grown from solutions,” Polymer Journal, vol. 41, no. 9, pp. 787–791, 2009.
[20]
T. Sasaki, D. Morino, and N. Tabata, “Origin of enhanced cold crystallization rate for freeze-dried poly(L-lactide) from solutions,” Polymer Engineering and Science, vol. 51, no. 9, pp. 1858–1865, 2011.
[21]
E. W. Fischer, H. J. Sterzel, and G. Wegner, “Investigation of the structure of solution grown crystals of lactide copolymers by means of chemical reactions,” Kolloid-Zeitschrift & Zeitschrift für Polymere, vol. 251, no. 11, pp. 980–990, 1973.
[22]
P. Sarazin, X. Roy, and B. D. Favis, “Controlled preparation and properties of porous poly(L-lactide) obtained from a co-continuous blend of two biodegradable polymers,” Biomaterials, vol. 25, no. 28, pp. 5965–5978, 2004.
[23]
P. L. Ritger and N. A. Peppas, “A simple equation for desciption of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs,” Journal of Controlled Release, vol. 5, no. 1, pp. 23–36, 1987.